Education
About Us
Working with TipRanks
Follow Us
Bruker Corp (BRKR)
NASDAQ:BRKR
BRKR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$43.51 - $94.52
Previous CloseN/A
Volume340.61K
Average Volume (3M)2.08M
Market Cap
$6.74B
Enterprise Value$12.80B
Total Cash (Recent Filing)$340.10M
Total Debt (Recent Filing)$1.46B
Price to Earnings (P/E)58.8
Beta1.04
Next Earnings
Apr 30, 2025EPS Estimate
0.42Last Dividend Ex-Date
Mar 17, 2025Dividend Yield0.45%
Share Statistics
EPS (TTM)0.76
Shares Outstanding151,705,170
10 Day Avg. Volume2,114,141
30 Day Avg. Volume2,075,898
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.00
Price to Cash Flow (P/CF)8.90
P/FCF Ratio10.50
Enterprise Value/Market Cap1.90
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit7.76
Enterprise Value/Ebitda29.69
Forecast
1Y Price Target
$69.75Price Target Upside56.74% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
---
Bruker News
PremiumCompany Announcements
Bruker Expands Board with Appointment of Laura Francis
PremiumCompany Announcements
Bruker Corporation’s Earnings Call Highlights Robust Growth
---
Bulls Say, Bears Say
Bulls Say
Growth ProspectsBRKR guided for three GHz-class NMR placements entering 2025, with potential to deliver the same number as in 2024, which indicates growth prospects.
Innovative ProductsBRKR's innovative product rollouts, such as the CosMx WTX panel and PaintScape platform, are expected to generate significant interest from researchers.
ValuationThe valuation of Bruker Corporation is not demanding, at 14x EBITDA/18x PE, and seems to already account for potential negative news.
Bears Say
Market ConcernsQuestions around BRKR are likely to persist until there is more clarity around NIH funding.
NIH Funding ConcernsThe lingering uncertainty around NIH funding is likely to have some impact, just not yet.
Revenue PerformanceRevenues missed at midpoint mostly due to FX drag, affecting overall performance.
---
Ownership Overview
26.37% Insiders
30.04% Mutual Funds
6.37% Other Institutional Investors
20.78% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BRKR FAQ
What was Bruker Corp’s price range in the past 12 months?
Bruker Corp lowest stock price was $43.51 and its highest was $94.52 in the past 12 months.
What is Bruker Corp’s market cap?
Bruker Corp’s market cap is $6.74B.
When is Bruker Corp’s upcoming earnings report date?
Bruker Corp’s upcoming earnings report date is Apr 30, 2025 which is in 36 days.
How were Bruker Corp’s earnings last quarter?
Bruker Corp released its earnings results on Feb 13, 2025. The company reported $0.76 earnings per share for the quarter, beating the consensus estimate of $0.737 by $0.023.
Is Bruker Corp overvalued?
According to Wall Street analysts Bruker Corp’s price is currently Undervalued.
Does Bruker Corp pay dividends?
Bruker Corp pays a Quarterly dividend of $0.2 which represents an annual dividend yield of 0.45%. See more information on Bruker Corp dividends here
What is Bruker Corp’s EPS estimate?
Bruker Corp’s EPS estimate is 0.42.
How many shares outstanding does Bruker Corp have?
Bruker Corp has 151,705,170 shares outstanding.
What happened to Bruker Corp’s price movement after its last earnings report?
Bruker Corp reported an EPS of $0.76 in its last earnings report, beating expectations of $0.737. Following the earnings report the stock price went down -0.969%.
Which hedge fund is a major shareholder of Bruker Corp?
Currently, no hedge funds are holding shares in BRKR
---
Bruker Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$69.75 (56.74% Upside)
$69.75 (56.74% Upside)
Blogger Sentiment
Bullish
BRKR Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 109.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $1.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.2%
Last 30 Days ▲ 2.4%
Last 30 Days ▲ 2.4%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-52.44%
12-Months-Change
Fundamentals
Return on Equity
7.16%
Trailing 12-Months
Asset Growth
36.63%
Trailing 12-Months
Company Description
Bruker Corp
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
---
BRKR Company Deck
---
BRKR Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Bruker's earnings call highlighted strong revenue growth and strategic acquisition successes, positioning the company well for future growth. However, challenges such as NIH funding uncertainty, China market softness, and initial M&A dilution present headwinds. Despite these challenges, the company remains focused on margin expansion and EPS growth.Read More>---
BRKR Stock 12 Month Forecast
Average Price Target
$69.75
▲(56.74% Upside)
Technical Analysis
Best Analysts Covering BRKR
1 Year
1 Year Success Rate
15/29 ratings generated profit
1 Year Average Return
+4.87%
reiterated a buy rating 20 days ago
Copying Brandon Couillard's trades and holding each position for 1 Year would result in 51.72% of your transactions generating a profit, with an average return of +4.87% per trade.
---